European consumer staples firms operating in beauty are navigating a market that is becoming increasingly selective, with brand standing and product innovation determining which companies capture consumer spending. Barclays has highlighted L'Oreal as particularly well-positioned, drawing on constructive signals from Puig's first-half results.
Puig reported 4.4% like-for-like (LFL) growth in the first half, with gains across geographies and business lines. Management kept guidance intact, reiterating its expectation to outperform the premium beauty market through fiscal 2026 while maintaining stable adjusted EBITDA margins.
Barclays' view that L'Oreal can benefit from Puig's results rests on several category-level trends revealed by Puig's disclosure. The overall beauty market continues to expand, but performance is uneven across segments. Fragrance and makeup remain dynamic, while dermocosmetics are taking share. By contrast, premium skincare has softened as consumers prioritize products that demonstrate efficacy and deliver stronger value propositions.
Within Puig's results, the company flagged near 4% growth in the fragrance market in H1, alongside double-digit expansion in niche fragrance and derma categories. Puig's skincare business grew 2.3% LFL in the period, aided by Uriage, whose dermocosmetics offerings achieved double-digit growth. Those contrasts - stronger dermocosmetics performance versus softer premium skincare - are part of the rationale Barclays cites in singling out L'Oreal, given its derma strength and brand credibility.
Puig's Fragrance & Fashion segment expanded 3.8% LFL in H1, and the company reported a 0.3 percentage point increase in fragrance value share driven by brands such as Carolina Herrera. The makeup category posted robust expansion, up 9.1% LFL, led by Charlotte Tilbury, which gained 0.4 percentage points of share. Barclays notes that fragrance and premium makeup remain attractive areas for L'Oreal's Luxe portfolio.
Regional performance in Puig's H1 showed marked divergence. APAC led with 20.9% LFL growth in the period, driven by niche fragrance and strong consumer demand. EMEA and the Americas both recorded 2.6% LFL growth. Barclays observed that while Puig performed adequately in developed markets, L'Oreal is delivering stronger outcomes, with approximately 7% growth in both the United States and Europe.
Recent corporate developments also inform Barclays' stance. L'Oreal signed a 50-year exclusive beauty license agreement with Gucci and plans to launch the first products under that arrangement in 2028. Separately, Exane BNP Paribas upgraded L'Oreal from underperform to neutral, citing the company's ability to navigate inflationary pressures.
Takeaway - Barclays interprets Puig's H1 performance as evidence that selective category strength - particularly in fragrance, premium makeup and dermocosmetics - is shaping winners and losers in beauty. L'Oreal's derma positioning, brand strength and recent strategic moves have led Barclays to view it as a key beneficiary of these dynamics.
Key Points
- Puig reported 4.4% like-for-like growth in H1, with gains across all geographies and segments.
- Category divergence is pronounced: fragrance, makeup and dermocosmetics are growing while premium skincare is softer as consumers seek proven efficacy and value.
- Regional split showed APAC leading with 20.9% LFL growth; EMEA and Americas each posted 2.6% LFL growth, while L'Oreal is delivering roughly 7% growth in the US and Europe according to Barclays.
Risks and Uncertainties
- Softening in premium skincare could weigh on companies heavily exposed to that segment if consumers continue to favor efficacy and value over premium positioning - impacting skincare and broader consumer staples sectors.
- Category and regional divergence introduces volatility; reliance on APAC's strong growth could expose firms to concentrated geographic risk in the beauty and retail sectors.
- Assumptions around maintaining stable adjusted EBITDA margins and outperforming the premium beauty market through fiscal 2026 are contingent on execution and market conditions.